Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost Infusion on Muscle Perfusion and Glucose Uptake in Type 2 Diabetes
NCT03380325Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of iloprost in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Rate of disappearance and Capillary recruitment. Started May 2016; status: completed.
02
Drugs
iloprost
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03380325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380325.